These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10855462)

  • 21. Experiences with clozapine and olanzapine.
    Chatterton R
    Aust N Z J Psychiatry; 1998 Jun; 32(3):463. PubMed ID: 9672741
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of olanzapine and clozapine upon pulse rate variability.
    Mueck-Weymann M; Rechlin T; Ehrengut F; Rauh R; Acker J; Dittmann RW; Czekalla J; Joraschky P; Musselman D
    Depress Anxiety; 2002; 16(3):93-9. PubMed ID: 12415532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response.
    Conley RR; Tamminga CA; Kelly DL; Richardson CM
    Biol Psychiatry; 1999 Jul; 46(1):73-7. PubMed ID: 10394475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
    Meltzer HY; Alphs L; Green AI; Altamura AC; Anand R; Bertoldi A; Bourgeois M; Chouinard G; Islam MZ; Kane J; Krishnan R; Lindenmayer JP; Potkin S;
    Arch Gen Psychiatry; 2003 Jan; 60(1):82-91. PubMed ID: 12511175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olanzapine and sulpiride: a preliminary study of combination/augmentation in patients with treatment-resistant schizophrenia.
    Raskin S; Durst R; Katz G; Zislin J
    J Clin Psychopharmacol; 2000 Oct; 20(5):500-3. PubMed ID: 11001233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
    Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA
    Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Massive increase in serum creatine kinase during olanzapine and quetiapine treatment, not during treatment with clozapine.
    Boot E; de Haan L
    Psychopharmacology (Berl); 2000 Jun; 150(3):347-8. PubMed ID: 10923763
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S; Zipursky RB; Remington G
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
    Dias Alves M; Micoulaud-Franchi JA; Simon N; Vion-Dury J
    J Clin Psychopharmacol; 2018 Dec; 38(6):555-562. PubMed ID: 30247179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined use of risperidone and olanzapine in the treatment of patients with resistant schizophrenia: a preliminary case series report.
    Lerner V; Chudakova B; Kravets S; Polyakova I
    Clin Neuropharmacol; 2000; 23(5):284-6. PubMed ID: 11154098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents.
    Melkersson KI; Hulting AL
    Psychopharmacology (Berl); 2001 Mar; 154(2):205-12. PubMed ID: 11314683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some aspects of psychodynamic response to novel atypical antipsychotics.
    Murawiec S; Taflińska D; Tafliński T
    Harv Rev Psychiatry; 1999; 7(4):241-2. PubMed ID: 10579106
    [No Abstract]   [Full Text] [Related]  

  • 35. Olanzapine augmentation of clozapine.
    Gupta S; Sonnenberg SJ; Frank B
    Ann Clin Psychiatry; 1998 Sep; 10(3):113-5. PubMed ID: 9781474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia.
    Schuld A; Kraus T; Hinze-Selch D; Haack M; Pollmächer T
    Acta Psychiatr Scand; 2000 Aug; 102(2):153-5. PubMed ID: 10937789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol.
    Tauscher J; Küfferle B; Asenbaum S; Fischer P; Pezawas L; Barnas C; Tauscher-Wisniewski S; Brücke T; Kasper S
    Psychopharmacology (Berl); 1999 Jan; 141(2):175-81. PubMed ID: 9952042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine?
    Eschweiler GW; Bartels M; Längle G; Wild B; Gaertner I; Nickola M
    Pharmacopsychiatry; 2002 May; 35(3):96-100. PubMed ID: 12107853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. The Collaborative Crossover Study Group.
    Tollefson GD; Dellva MA; Mattler CA; Kane JM; Wirshing DA; Kinon BJ
    J Clin Psychopharmacol; 1999 Oct; 19(5):435-43. PubMed ID: 10505585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
    Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
    J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.